NetworkNewsBreaks – Xeris Pharmaceuticals, Inc. (NASDAQ: XERS) Featured in Mizuho Securities Research Report
Xeris Pharmaceuticals, Inc. (NASDAQ: XERS) was featured in a recent equity research report published by Mizuho Securities USA LLC. The report reads, “In our bull case scenario, we assume greater than expected uptake of the Xeris glucagon rescue pen. We project peak market share reaching ~60% for total U.S. peak sales of$494mn in 2029. In addition, we also apply a higher multiple of 5x in our EV/Sales methodology to account for higher growth. This translates into a $25 PT” To request access to the full report, visit http://nnw.fm/SaZ9d About Xeris Pharmaceuticals, Inc. Xeris is a specialty pharmaceutical company delivering innovative…







